PTC THERAPEUTICS INC's ticker is and the CUSIP is 69366JAB7. A total of 10 filers reported holding PTC THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $12,829,000 | +285.7% | 12,663,000 | +287.4% | 0.15% | +325.7% |
| Q1 2022 | $3,326,000 | +49.9% | 3,269,000 | +63.4% | 0.04% | -16.7% |
| Q2 2019 | $2,219,000 | -76.5% | 2,000,000 | -75.6% | 0.04% | -66.9% |
| Q3 2018 | $9,454,000 | +175.7% | 8,200,000 | +138.0% | 0.13% | +164.6% |
| Q2 2018 | $3,429,000 | -60.8% | 3,445,000 | -63.4% | 0.05% | -65.5% |
| Q1 2018 | $8,757,000 | +18.1% | 9,400,000 | -1.2% | 0.14% | +19.8% |
| Q4 2017 | $7,417,000 | -11.9% | 9,510,000 | -8.2% | 0.12% | -7.9% |
| Q3 2017 | $8,417,000 | +10.5% | 10,355,000 | +6.8% | 0.13% | +0.8% |
| Q2 2017 | $7,617,000 | +350.4% | 9,700,000 | +273.1% | 0.12% | +400.0% |
| Q1 2017 | $1,691,000 | – | 2,600,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 24,877,000 | $25,902,000 | 1.06% |
| PFM Health Sciences, LP | 19,807,000 | $20,605,000 | 0.61% |
| Partner Investment Management, L.P. | 193,000 | $201,000 | 0.34% |
| DeepCurrents Investment Group LLC | 4,430,000 | $4,581,000 | 0.31% |
| WOLVERINE ASSET MANAGEMENT LLC | 20,454,000 | $21,253,000 | 0.27% |
| FARALLON CAPITAL MANAGEMENT LLC | 24,176,000 | $25,210,000 | 0.19% |
| PALISADE CAPITAL MANAGEMENT, LP | 2,300,000 | $2,381,000 | 0.07% |
| Verition Fund Management LLC | 1,415,000 | $1,472,000 | 0.04% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 4,298,000 | $4,470,000 | 0.03% |
| LOOMIS SAYLES & CO L P | 248,482 | $8,404,000 | 0.02% |